APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401

APEIRON to utilize MaxCyte’s ExPERT® platform for siRNA-based cell therapy APN401 targeting solid tumors and secures manufacturing for upcoming clinical trials VIENNA, AUSTRIA and GAITHERSBURG, MD, July 8, 2020 APEIRON Biologics AG (“APEIRON”), a private biotechnology company specializing in the discovery, development and commercialization of novel immunotherapies for cancer and respiratory diseases, and MaxCyte, Inc., a […]

Protaryx Medical Announces $8.3M in Funding for First-in-Class Technology for Left Atrial Access in Transcatheter Cardiac Procedures

$5.1M Series A Funding Led by Ajax Health Will Be Used to Develop First-in-Class Product Designed with Three-Dimensional, Independent Steerability to Deliver Reliable Access BALTIMORE–(BUSINESS WIRE)–Protaryx™ Medical, a company committed to reimagining access to the left atrium for transcatheter cardiac procedures, today announced that it has raised $8.3 million in funding to develop the company’s […]

BioBuzz: Former MedImmune Employees Leading In the BioHealth Capital Region and Beyond

In a recent conversation someone shared the quote “You can’t throw a stone in the BioHealth Capital Region and not hit somebody who worked at MedImmune”. This statement emphasizes how important the company was in seeding the growth of the biotech industry in Maryland. Founded by Wayne T. Hockmeyer in 1988 as Molecular Vaccines, Inc., […]

UMB Startup Breethe Acquired by Abiomed to Commercialize Wearable Artificial Lung System

The Deal Marks Another Successful Exit Supported by UM Ventures Breethe, a company built on technology licensed out of the University of Maryland, Baltimore (UMB), was acquired by Abiomed, a publicly-traded medical device company located in Massachusetts, in late April 2020. Financials were not disclosed, but the deal represents another UMB success story that received early backing […]

MaxCyte to Share Preliminary Phase I Data on MCY-M11 at ASCO 2020 Annual Meeting

Gaithersburg, Maryland – May 18, 2020: – MaxCyte, the global clinical-stage cell-based therapies and life sciences company, announces that clinical data from the first three cohorts of the ongoing Phase I dose-escalation trial demonstrating safety of MCY-M11 and feasibility of one-day manufacturing will be shared at the American Society of Clinical Oncology’s (ASCO) upcoming annual meeting. […]

CapitalM ZoomCast Live – COVID Series — A Discussion with Jim Hughes: Advancing UMB-Born Technologies in the Fight Against COVID-19 & Beyond

Marty Rosendale’s guest, Jim Hughes, Senior Vice President and Chief Enterprise & Economic Development Officer at University of Maryland, Baltimore shared how university physicians, faculty/researchers and tech transfer professionals are working to bring innovations to life to help clinicians on the front line treat patients and fight COVID-19. Watch here » | Listen here »

UMB Grants Pumas-AI Exclusive License for Lyv, a Cutting-Edge Clinical Decision Support System

Company spun out of University of Maryland School of Pharmacy aims to leverage its approach — combining modern artificial intelligence (AI) with traditional mechanistic models — to arm health care professionals with the best data to provide personalized treatment trajectories for patients BALTIMORE, May 7, 2020 /PRNewswire/ — Pumas-AI, a University of Maryland, Baltimore (UMB) startup company, has been granted worldwide, exclusive rights […]

Technical.ly Baltimore: UMB-born medical device company Breethe acquired by Abiomed

The Halethorpe-based company’s lung-like technology will become part of the product portfolio of Massachusetts’ Abiomed. Breethe, the medical device company founded by renowned University of Maryland School of Medicine surgeon and professor Dr. Bartley Griffith, has been acquired by Danvers, Massachusetts-based Abiomed, the companies announced this week. Breethe’s system, which is designed to behave like a human lung, will […]

UM Ventures Backs Innovative UMB Startup Programs and Technologies to Aid Clinicians in the Fight Against COVID-19 Pandemic

Following the initial outbreak of coronavirus (COVID-19) in the US, most of the public’s attention was focused on finding hand sanitizer, toilet paper and face masks. While these resources are imperative to help prevent the spread of the virus, there is a dire need for more healthcare technology that will directly impact the treatment of […]

BioProcess International: Allogene turns to MaxCyte’s tech for its off-the-shelf CAR-T therapies

MaxCyte says its clinically validated electroporation technology will help increase efficiency and improve yield of Allogene’s allogeneic CAR-T therapy candidates. Pfizer-backed biotech Allogene launched in 2018 with a focus on developing allogeneic, or off-the-shelf, chimeric antigen receptor (CAR) T-cell therapies. To achieve this, the firm has regularly stressed the importance of manufacturing, devoting “considerable time and resources” to […]

PressComm

News